Abstract:Background: Patients with acute coronary syndrome due to left main and/or three-vessel disease (LM/3VD) are at the highest risk of adverse cardiovascular events. Neutrophil to lymphocyte ratio (NLR) has been proposed as a marker of cardiovascular risk,but the prognostic value of NLR in patients with LM/3VD who underwent percutaneous coronary intervention (PCI) is not clearly deﬁned. We sought to evaluate the independent predictive value of NLR for LM/3VD in AMI patients. Methods: Patients (n=806) admitted with LM/3VD in AMI and who underwent PCI between January 2013 and December 2013 were followed up for 2 years. NLR was calculated as the ratio of neutrophil to lymphocyte based on the labo- ratory data on admission. The primary end point was all-cause death. The secondary end point was long-term major adverse cardiovascular and cerebrovas- cular events (MACCE). We used Cox regression models to examine the relation between NLR and clinical outcomes. Results: In of the and of Methods: Freshly isolated cells from MI patients were treated with recombinant human cytokines (TNF-a, IL-1b, IL-6, IL-7 and IL-15) and the number, activation, function and proliferation of CD28null T cells were analysed. Results: We found that pro-inﬂammatory cytokines TNF-a, IL-1b and IL-6 did not have any effect on CD28null T cell number. Strikingly, homeostatic cytokines IL- 7 and IL-15 triggered expansion of CD28null T cells from MI patients, which was mediated by cell proliferation. Moreover, we demonstrate for the ﬁrst time that IL-7 and IL-15 activate CD28null T cells and increase their cytotoxic function. Conclusions: We showed that IL-7 and IL-15 and not pro-inﬂammatory cytokines are the main drivers of CD28null T cell expansion in MI patients. Our novel ﬁndings suggest that anti-inﬂammatory drugs targeting TNF-a, IL-1 and IL-6 may fail to control CD28null T cell expansion in MI patients and that therapeutic strategies targeting alternative cytokines (IL-7, IL-15) may be beneﬁcial. Soluble Methods: We measured plasma suPAR by ELISA in 62 patients with non- obstructive coronary artery disease (CAD, fractional ﬂow reserve > 0.75) who underwent radiofrequency IVUS (VH-IVUS). The association between suPAR lev- els and VH-IVUS-deﬁned plaque burden (plaque area/vessel area × 100) and composition (necrotic core, dense calcium, and ﬁbrous and ﬁbrofatty tissue) was characterized using univariable and multivariable analyses. Multivariable analyses adjusted for age, sex, eGFR, diabetes, and hypertension. Results: Median age was 57 (IQR 48, 63) years, 51% men, 23% diabetic, and 71% hypertensive. Median suPAR level was 2.81 (IQR 1.99, 3.44) ng/mL and median plaque burden was 38 (IQR 27, 48)%. In univariable analyses, suPAR levels correlated with percent necrotic core (r=+0.30, p=0.02) and percent dense calcium (r=+0.27, 0.04) among plaque components. These associations remained signiﬁcant in multivariable analyses adjusting for the aforementioned factors ( β =+0.24 [0.01, 1.04], p=0.047 and β =+0.23 [0.03, 1.07], p=0.038, re-spectively). There was no correlation between suPAR levels and plaque burden. secondary to increased plaque vulnerability (high risk plaque) in those with elevated suPAR levels. Background: MAIR-II (Myeloid-Associated Immunoglobulin-Like Receptor II) is expressed on myeloid cells and is involved in Toll-like receptor-4 (TLR4)-mediated inﬂammatory monocyte migration from the blood to sites of infection as part of the host response in polymicrobial peritonitis. Following myocardial infarction (MI), monocytes are known to be recruited to infarcted myocardium. However, the un- derlying mechanism is not yet completely understood. Purpose: To investigate the role of MAIR-II in MI pathophysiology. Methods and results: In ﬂow cytometric analysis, MAIR-II+ myeloid cells were abundant from post-MI days 3 to 5 in infarcted hearts induced by permanent lig- ation of the left coronary artery. To address the role of MAIR-II in myeloid cell function in vivo, effects of MAIR-II deﬁciency were investigated. In echocardio- graphy, MAIR-II knockout (KO) mice had thicker left ventricle posterior walls and higher ejection fractions compared to wild-type (WT) mice. This indicates that MAIR-II deﬁciency leads to favorable post-MI remodelling. After further investi-gation, we found that MAIR-II KO hearts had less macrophage inﬂux and more neutrophil | Background: Statins can contribute to the stabilization of coronary plaques. Purpose: The aim of the present study was to assess the effect of early statin therapy on ﬁbrous cap thickness in coronary plaques of acute coronary syndrome (ACS) patients by using optical coherence tomography (OCT).

Circulating Regulatory B-Lymphocytes in Patients with Acute Myocardial Infarction: A Pilot Study

Impact Of Increased Inflammation Biomarkers On Periprocedural Myocardial Infarction In Patients Undergoing Elective Percutaneous Coronary Intervention: A Cohort Study

Immune Cell Repertoire And Their Mediators In Patients With Acute Myocardial Infarction Or Stable Angina Pectoris

Regulatory T Lymphocytes in Myocardial Infarction: A Promising New Therapeutic Target

Dynamic Profile of CD4+ T-Cell-Associated Cytokines/Chemokines Following Murine Myocardial Infarction/Reperfusion

Coronary artery disease: from bench to bedside Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction in

Characteristics of B Cell-Associated Gene Expression in Patients with Coronary Artery Disease

Plasma Macrophage Migration Inhibitor Factor is Elevated in Response to Myocardial Ischemia

Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration

Single-Cell RNA Sequencing of Peripheral Blood Mononuclear Cells From Acute Myocardial Infarction

Recruitment of myeloid-derived suppressor cells and regulatory T-cells is associated with the occurrence of acute myocardial infarction

The Role of CD27-CD70 Signaling in Myocardial Infarction and Cardiac Remodeling

Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial Infarction

Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction

Lower Prevalence of Circulating Invariant Natural Killer T (inkt) Cells in Patients with Acute Myocardial Infarction Undergoing Primary Coronary Stenting

Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients

Regulatory T cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction

Integrated Whole-Genome Gene Expression Analysis Reveals an Atlas of Dynamic Immune Landscapes after Myocardial Infarction.

Circulating Mir-181a As A Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction

IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction

New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications